Vitrakvi Capsules 100mg, from Bayer Pharmaceutical, contains Larotrectinib sulfate (YJ code: 4291071M2025, standard: 100mg 1 capsule). This antineoplastic agent acts as a selective tropomyosin receptor kinase (TRK) inhibitor, designed to block TRK fusion proteins that contribute to uncontrolled cell proliferation in various solid tumors.
Vitrakvi Capsules 100mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
